Gemcitabine Pharmacokinetics After Preoperative Chemoradiation Therapy
Status:
Terminated
Trial end date:
2019-06-03
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if gemcitabine given during surgery can
enter pancreas cancer cells in patients who have already received chemotherapy and radiation.
Gemcitabine is a drug used to treat pancreatic cancer. However, it has not previously been
studied if gemcitabine can enter pancreatic cancer cells. Gemcitabine is designed to block
the growth of cancer cells, which may cause cancer cells to die.